Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts-Reference-Cited by-同舟云学术

Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts

Published:2017-05 Issue:5 Volume:23 Page:805-812
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Green Kile,Pearce Kim,Sellar Rob S.,Jardine Laura,Nicolson Phillip L.R.,Nagra Sandeep,Bigley Venetia,Jackson Graham,Dickinson Anne M.,Thomson Kirsty,Mackinnon Stephen,Craddock Charles,Peggs Karl S.,Collin Matthew^ORCID

Funder

Bright Red

British Society for Haematology

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference36 articles.

1. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation;Kottaridis;Blood,2000

2. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen;Chakraverty;Blood,2002

3. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia;Tauro;J Clin Oncol,2005

4. Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study;Delgado;Blood,2006

5. Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML;Malladi;Bone Marrow Transplant,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention;Blood Advances;2024-08-15

2. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial;The Lancet Haematology;2022-04

3. The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges;Viruses;2022-01-10

4. Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia;Frontiers in Pediatrics;2022-01-06

5. Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation;Transplantation and Cellular Therapy;2021-08